A phase 3, multicenter, randomized, allopurinol‐controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

Publisher: John Wiley & Sons Inc

E-ISSN: 1756-185x|18|6|669-678

ISSN: 1756-1841

Source: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.6, 2015-07, pp. : 669-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content